Advertisement

Annals of Surgical Oncology

, Volume 26, Issue 13, pp 4372–4380 | Cite as

An In-Visit Decision Aid for Surgeons to Address Decision Making for Bilateral Mastectomy for Newly Diagnosed Breast Cancer Patients

  • Katharine YaoEmail author
  • Jeff Belkora
  • Clara Lee
  • Kristine Kuchta
  • Catherine Pesce
  • Katherine Kopkash
  • Sarah Rabbitt
  • Ermilo Barrera
  • Sandra Simovic
  • Karen Sepucha
Breast Oncology

Abstract

Background

Few decision aids for newly diagnosed breast cancer patients are used by surgeons during their consultations with patients.

Methods

From 2017 to 2019, an online interactive breast cancer in-visit decision aid (BIDA) was used on 63 patients and 57 patients underwent usual care (UC). We compared knowledge, decision involvement, anxiety and distress (HADS scale), quality of life (PROMIS), fear of recurrence, body image, and patient values between BIDA and UC before surgery. A knowledge score of ≥ 57% was considered “high knowledge.”

Results

A total of 188 patients were enrolled of which 120 (63.8%) completed all study procedures. Patient demographic characteristics and anxiety and quality of life (QOL) at baseline were similar between patients in BIDA and UC cohorts. After seeing the surgeon, patients in the BIDA group had higher composite knowledge scores compared with UC patients [n = 55 (87.3%) vs. n = 39 (68.4%) respectively, p = 0.012]. Patients in the BIDA cohort reported being asked more often their surgical preference (p = 0.013) and discussing bilateral mastectomy (BM) as an option (p = 0.048). There was a trend of less patients in the BIDA cohort undergoing BM then in the UC cohort [10 (15.9%) vs. 14 (24.6%), p = 0.49]. Anxiety and distress, QOL, fear of recurrence, and body image were not significantly different between BIDA and UC cohorts.

Conclusions

A decision aid used by surgeons during their consultation was associated with higher knowledge levels, patients reporting more discussion about BM, and a trend of lower BMs. A larger study with more patients is needed to confirm this finding.

Notes

Acknowledgement

None to report.

Disclosures

The authors declare no conflicts of interest and no disclosures.

Supplementary material

10434_2019_7912_MOESM1_ESM.pdf (5.2 mb)
Supplementary material 1 (PDF 5353 kb)
10434_2019_7912_MOESM2_ESM.docx (27 kb)
Supplementary material 2 (DOCX 26 kb)

References

  1. 1.
    Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg. 2015;150(1):9–16.CrossRefGoogle Scholar
  2. 2.
    Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203–9.CrossRefGoogle Scholar
  3. 3.
    Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27(9):1362–7.CrossRefGoogle Scholar
  4. 4.
    Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998–2007. Ann Surg Oncol. 2010;17(10):2554–62.CrossRefGoogle Scholar
  5. 5.
    NCCN guidelines. 2019; Availabel at: https://www.nccn.org. Accessed July 2019.
  6. 6.
    Boughey JC, Attai DJ, Chen SL, et al. Contralateral Prophylactic Mastectomy (CPM) consensus statement from the American Society of Breast Surgeons: data on CPM outcomes and risks. Ann Surg Oncol. 2016;23(10):3100–5.CrossRefGoogle Scholar
  7. 7.
    Boughey JC, Attai DJ, Chen SL, et al. Contralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: additional considerations and a framework for shared decision making. Ann Surg Oncol. 2016;23(10):3106–11.CrossRefGoogle Scholar
  8. 8.
    Choosing Wisely: Promoting Conversations between Patients and Clinicians. 2019; www.choosingwisely.org. Accessed July 2019.
  9. 9.
    Bellavance E, Peppercorn J, Kronsberg S, et al. Surgeons’ perspectives of contralateral prophylactic mastectomy. Ann Surg Oncol. 2016. 23(9):2779–87.CrossRefGoogle Scholar
  10. 10.
    Musiello T, Bornhammar E, Saunders C. Breast surgeons’ perceptions and attitudes towards contralateral prophylactic mastectomy. ANZ J Surg. 2013;83(7–8):527–32.CrossRefGoogle Scholar
  11. 11.
    Stacey D, Legare F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4:CD001431.PubMedGoogle Scholar
  12. 12.
    Jagsi R, Hawley ST, Griffith KA, et al. Contralateral prophylactic mastectomy decisions in a population-based sample of patients with early-stage breast cancer. JAMA Surg. 2017;152(3):274–82.CrossRefGoogle Scholar
  13. 13.
    Katz SJ, Janz NK, Abrahamse P, et al. Patient reactions to surgeon recommendations about contralateral prophylactic mastectomy for treatment of breast cancer. JAMA Surg. 2017;152(7):658–64.CrossRefGoogle Scholar
  14. 14.
    Katz SJ, Hawley ST, Hamilton AS, et al. Surgeon influence on variation in receipt of contralateral prophylactic mastectomy for women with breast cancer. JAMA Surg. 2018;153(1):29–36.CrossRefGoogle Scholar
  15. 15.
    Hawley ST, Newman L, Griggs JJ, Kosir MA, Katz SJ. Evaluating a decision aid for improving decision making in patients with early-stage breast cancer. Patient. 2016;9(2):161–9.CrossRefGoogle Scholar
  16. 16.
    Whelan T, Levine M, Willan A, et al. Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA. 2004;292(4):435–41.CrossRefGoogle Scholar
  17. 17.
    Yao K, Belkora J, Bedrosian I, et al. Impact of an in-visit decision aid on patient knowledge about contralateral prophylactic mastectomy: a pilot study. Ann Surg Oncol. 2017;24:91–9.CrossRefGoogle Scholar
  18. 18.
    Belkora J. 2016; www.scoped.com. Accessed July 2019.
  19. 19.
    Belkora JK, Loth MK, Volz S, Rugo HS. Implementing decision and communication aids to facilitate patient-centered care in breast cancer: a case study. Patient Educ Couns. 2009;77(3):360–8.CrossRefGoogle Scholar
  20. 20.
    Joseph-Williams N, Newcombe R, Politi M, et al. Toward minimum standards for certifying patient decision aids: a modified delphi consensus process. Med Decis Mak. 2013;34(6):699–710.CrossRefGoogle Scholar
  21. 21.
    Collins ED, Moore CP, Clay KF, et al. Can women with early-stage breast cancer make an informed decision for mastectomy? J Clin Oncol. 2009;27(4):519–25.CrossRefGoogle Scholar
  22. 22.
    Bretscher M, Rummans T, Sloan J, et al. Quality of life in hospice patients. A pilot study. Psychosomatics. 1999;40(4):309–13.CrossRefGoogle Scholar
  23. 23.
    Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63(11):1179–94.CrossRefGoogle Scholar
  24. 24.
    Sepucha KR, Belkora JK, Chang Y, et al. Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery. BMC Med Inform Decis Mak. 2012;12:51.CrossRefGoogle Scholar
  25. 25.
    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRefGoogle Scholar
  26. 26.
    Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009;124(2):345–53.CrossRefGoogle Scholar
  27. 27.
    Kornblith AB, Powell M, Regan MM, et al. Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer. Psychooncology. 2007;16(10):895–903.CrossRefGoogle Scholar
  28. 28.
    Greenberg DB, Kornblith AB, Herndon JE, et al. Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971–1988: predictors for later psychologic distress. Cancer. 1997;80(10):1936–44.CrossRefGoogle Scholar
  29. 29.
    Hersch J, Barratt A, Jansen J, et al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet. 2015;385(9978):1642–52.CrossRefGoogle Scholar
  30. 30.
    Sepucha K, Ozanne E, Silvia K, Partridge A, Mulley AG Jr. An approach to measuring the quality of breast cancer decisions. Patient Educ Couns. 2007;65(2):261–9.CrossRefGoogle Scholar
  31. 31.
    Abbott A, Rueth N, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T. Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol. 2011;18(11):3129–36.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  • Katharine Yao
    • 1
    • 6
    Email author
  • Jeff Belkora
    • 2
  • Clara Lee
    • 3
  • Kristine Kuchta
    • 4
  • Catherine Pesce
    • 1
    • 6
  • Katherine Kopkash
    • 1
    • 6
  • Sarah Rabbitt
    • 1
  • Ermilo Barrera
    • 1
    • 6
  • Sandra Simovic
    • 1
  • Karen Sepucha
    • 5
  1. 1.Division of Surgical Oncology, Department of SurgeryNorthShore University HealthSystemEvanstonUSA
  2. 2.University of California San Francisco School of MedicineSan FranciscoUSA
  3. 3.Division of Plastic Surgery, Department of SurgeryOhio State University Medical CenterColumbusUSA
  4. 4.Biostatistical CoreNorthShore University HealthSystem Research InstituteEvanstonUSA
  5. 5.Health Decision Sciences CenterMassachusetts General HospitalBostonUSA
  6. 6.Pritzker School of MedicineUniversity of ChicagoEvanstonUSA

Personalised recommendations